| 10.20 Data as of May 21 |  +0.31 / +3.13%Today’s Change | 2.76 Today|||52-Week Range 10.68 | +157.58% Year-to-Date |
| Previous close | 9.89 |
| Today’s open | 10.02 |
| Day’s range | 9.65 - 10.30 |
| Volume | 130,157 |
| Average volume (3 months) | 25,573 |
| Market cap | $71.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -150.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 209.62 |
| Today’s change | Today’s % change | |
|---|---|---|
| CBLICleveland BioLabs In... | -0.02 | -1.24% |
| ALXAAlexza Pharmaceutica... | +0.23 | +5.17% |
| --Ophthalix Inc | 0.00 | 0.00% |
| IGIGI Laboratories Inc | +0.02 | +1.23% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$3.3M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Nadav Kidron, MBA |
Chief Operating Officer & VP-Business Development Joshua Hexter |
Corporate headquarters Jerusalem, -- |
.
